Cargando…
Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres
BACKGROUND: The previous studies indicated that CrmA could ameliorate the interleukin-1β induced osteoarthritis. In this study, we investigated the controlled-released cytokine response modifier A (CrmA) from hyaluronic acid (HA)-chitosan (CS) microspheres to improve interleukin-1β (IL-1β)-stimulate...
Autores principales: | Ma, Bei-lei, Zhou, Pang-Hu, Xie, Ting, Shi, Lei, Qiu, Bo, Wang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384377/ https://www.ncbi.nlm.nih.gov/pubmed/25888442 http://dx.doi.org/10.1186/s12891-015-0521-6 |
Ejemplares similares
-
Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway
por: Dbaibo, Ghassan S., et al.
Publicado: (1997) -
Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes
por: Qiu, Bo, et al.
Publicado: (2016) -
A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA
Publicado: (1996) -
Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”
por: Qiu, Bo, et al.
Publicado: (2020) -
SPI-2/CrmA inhibits IFN-β induction by targeting TBK1/IKKε
por: Qin, Yue, et al.
Publicado: (2017)